Vossman discusses the genomics landscape, as well as next-generation sequencing (or NGS), and the Model Project, a ...
With the MiSeq™ i100 Series, Illumina continues to set the highest standards. Advancements in system design, sequencing chemistry, and data analysis deliver the simplest, fastest benchtop sequencing ...
Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...
Precision Psychiatry Market is projected to reach US$ 4.2 Bn by 2035, driven by rapid integration of AI and ML in psychiatric ...
According to MarketsandMarkets™, The report Single-molecule Real-time (SMRT) Sequencing Market is projected to grow from USD ...
GeneDx , a leader in delivering improved health outcomes through genomic insights, today announced that the GUARDIAN (Genomic Uniform-screening Against Rare Disease In All Newborns) study has been ...
India's hospital chains, diagnostics networks, and global investors have poured millions of dollars into gene sequencing, ...
Zacks Investment Research on MSN
Should Myriad Genetics stock stay in your portfolio right now?
Myriad Genetics, Inc. MYGN is well-poised to grow in the coming quarters due to its impressive cadence of product launches. The company is also progressing well in its refreshed long-term strategy to ...
If you are looking at Illumina and wondering whether today’s price really reflects its long term potential, you are not alone; this stock has gone from market darling to question mark and back again ...
In this interview, Dr. Gary Pestano and Dr. Prithwish Pal discuss the advantages ddPCR offers in molecular residual disease ...
The authors provide a useful integrated analytical approach to investigating MASLD focused on diverse multiomic integration methods. The strength of evidence for this new resource is solid, as ...
According to MarketsandMarketstm, The report Single-molecule Real-time (SMRT) Sequencing Market is projected to grow from USD 2.92 billion in 2025 and to reach 5.32 billion by 2030, at a Compound ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback